High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.
Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US
This achievement follows Bahrain’s landmark decision on 2 December 2023 to become the second country globally and the first ...
FOX 5 Atlanta on MSN7d
Cherokee County man cured of sickle cell anemia complications at Atlanta hospital, he says
Kyle Registre's childhood dream of becoming a pilot can finally come true now that he says he's been cured of sickle cell ...
Health Affairs7d
An Agenda For Sickle Cell Disease Research That Encompasses Lived Experience
As treatment and care continues to evolve, we must ensure that people living with this disease are able to advocate for ...
CRISPR: From Discovery To Clinic—And Charting A Path Forward
No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...
Medical Xpress9d
Sickle cell disease is a genetic disorder that causes lifelong suffering—here's what you need to know
In 2024, two forms of gene therapy were approved for sickle cell disease treatment by the US Food and Drug Administration. Both involve collecting stem cells from the patient, modifying them ...
St. Louis American5d
Wash U student study explores sickle cell impact on thinking
In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine ...
The Nation Newspaper3d
Not all sickle cell patients need bone marrow transplants – SCFN
National Director of the Sickle Cell Foundation Nigeria (SCFN), Dr. Annette Akinsete, has said that despite advancements in the treatment of sickle cell disease, not every patient requires a bone ...
Morningstar2d
Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US
This marks the first successful treatment of its kind outside the ... Casgevy (exagamglogene autotemcel), to sickle cell disorder and beta thalassaemia patients from all over the globe.
Yahoo Finance3d
Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US
MANAMA, Kingdom of Bahrain, Feb. 16, 2025 (GLOBE NEWSWIRE) -- The Bahrain Oncology Centre (BOC) has made medical history by successfully treating a sickle cell disease (SCD) patient using CRISPR ...